These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Who lives? (We all do now--but it wasn't always that way). Hartwell L Nephrol News Issues; 2009 Aug; 23(9):12-4. PubMed ID: 19753928 [No Abstract] [Full Text] [Related]
5. Technical and economic strategies of maintenance dialysis in the UK and Nordic Countries. Cantaluppi A; East P J Nephrol; 2000; 13 Suppl 3():S10-5. PubMed ID: 11132025 [TBL] [Abstract][Full Text] [Related]
7. Angio and peritoneal access for endstage renal disease in the community hospital: a cost analysis. Chapman JE; Sinicrope RA; Clark DM Am Surg; 1986 Jun; 52(6):315-9. PubMed ID: 3717777 [TBL] [Abstract][Full Text] [Related]
8. ESRD modality selection into the 21st century: the importance of non medical factors. Nissenson AR; Prichard SS; Cheng IK; Gokal R; Kubota M; Maiorca R; Riella MC; Rottembourg J; Stewart JH ASAIO J; 1997; 43(3):143-50. PubMed ID: 9152482 [No Abstract] [Full Text] [Related]
9. End-stage renal diseases in patients 75 and over: a new medical, socio-economical and ethical challenge. Mignon F; Michel C; Viron B; Mentre F; Jaar B Eur J Med; 1992 Sep; 1(5):302-7. PubMed ID: 1341612 [No Abstract] [Full Text] [Related]
11. Renal replacement therapy. 1-1. Introduction and review of dialysis and transplantation today. Stevens E Nurs Times; 1982 Apr 28-May 4; 78(17):700-4. PubMed ID: 7043409 [No Abstract] [Full Text] [Related]
12. [Selection of dialysis type--a crucial decision. Peritoneal dialysis is better for the patient and cheaper for the society]. Jonsdottir SS; Stenvinkel P; Bárány P Lakartidningen; 2005 Jan 31-Feb 6; 102(5):281-2. PubMed ID: 15754536 [No Abstract] [Full Text] [Related]
13. Peritoneal dialysis should be considered as the first line of renal replacement therapy for most ESRD patients. Burkart JM Blood Purif; 2001; 19(2):179-84. PubMed ID: 11150806 [No Abstract] [Full Text] [Related]
14. Economic evaluation of dialysis therapies. Klarenbach S; Manns B Semin Nephrol; 2009 Sep; 29(5):524-32. PubMed ID: 19751898 [TBL] [Abstract][Full Text] [Related]
15. Renal replacement therapy. 11. The cost of treating chronic renal failure. Pincherle G Nurs Times; 1982 Jul 7-13; 78(27):1153-4. PubMed ID: 6920717 [No Abstract] [Full Text] [Related]
16. [Peritoneal dialysis: used too little]. Fath R Dtsch Med Wochenschr; 2004 Mar; 129(11):544. PubMed ID: 15049316 [No Abstract] [Full Text] [Related]
17. Modality selection. Diaz-Buxo JA J Am Soc Nephrol; 1998 Dec; 9(12 Suppl):S112-7. PubMed ID: 11443757 [TBL] [Abstract][Full Text] [Related]
18. [Predicted need for renal dialysis in Israel]. Abramson JH; Czaczkes JW Harefuah; 1985 Apr; 108(8):379-82. PubMed ID: 4043847 [No Abstract] [Full Text] [Related]
19. Modality mix and the cost of dialysis. Blake PG Perit Dial Int; 2012; 32(2):125. PubMed ID: 22482130 [No Abstract] [Full Text] [Related]
20. Analysis of economic impact between the modality of renal replacement therapy. Gouveia DSES; Bignelli AT; Hokazono SR; Danucalov I; Siemens TA; Meyer F; Santos LS; Martins ZCL; Mierzwa TC; Furquim R J Bras Nefrol; 2017; 39(2):162-171. PubMed ID: 28489179 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]